Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, March 12, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Tags
AstraZeneca
Tag:
AstraZeneca
Latest Pharma-News
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
admin
-
May 8, 2023
0
Latest Pharma-News
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
admin
-
April 11, 2023
0
Latest Pharma-News
Ultomiris recommended for approval in EU for neuromyelitis optica spectrum disorder
admin
-
April 3, 2023
0
Latest Pharma-News
Calquence granted first regulatory approval in China for adults with previously treated mantle cell lymphoma
admin
-
March 24, 2023
0
Latest Pharma-News
AstraZeneca launches call for entries to 2023 global R&D Postdoctoral Challenge
admin
-
March 13, 2023
0
Latest Pharma-News
AZ’s acquisition with CinCor Pharma completed
admin
-
February 27, 2023
0
Latest Pharma-News
AZ enters license agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate
admin
-
February 23, 2023
0
Latest Pharma-News
Forxiga approved in EU for treatment of symptomatic chronic heart failure
admin
-
February 7, 2023
0
Latest Pharma-News
Tezspire recommended for approval in the EU by CHMP for the treatment of severe asthma
admin
-
July 25, 2022
0
Latest Pharma-News
AZ’s New study indicates that CKD is present in one out of ten adults
admin
-
July 1, 2022
0
Latest Pharma-News
AZ demonstrates pipeline and portfolio strength across malignant and rare haematological diseases at EHA 2022
admin
-
June 15, 2022
0
Latest Pharma-News
Enhertu granted Breakthrough Therapy Designation in US HER2-low metastatic breast cancer
admin
-
April 27, 2022
0
1
2
3
4
Page 1 of 4
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025